GuidelineDiabetes, obesity & metabolism2025

Triple oral therapy with metformin, DPP-4 inhibitor, and SGLT2 inhibitor for adults with type 2 diabetes: Consensus recommendations of a Chinese expert panel (version 2025).

Miao Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.